MICROBAC - Trademark Details
Status: 700 - Registered
Image for trademark with serial number 86698323
Serial Number
86698323
Registration Number
4986679
Word Mark
MICROBAC
Status
700 - Registered
Status Date
2016-06-28
Filing Date
2015-07-20
Registration Number
4986679
Registration Date
2016-06-28
Mark Drawing
4000 - Standard character mark Typeset
Published for Opposition Date
2016-04-12
Attorney Name
Law Office Assigned Location Code
M30
Employee Name
DICKEY, ERICA G.J.
Statements
Certificate of Correction for Registration
In the statement, line 19, "containing microorganisms and cultures of microorganisms" should be should be inserted after "products".
Goods and Services
Cultures of micro-organisms, namely, lactic acid bacteria and bifidobacteria used in the manufacture of food and pharmaceutical products, dietetic foods, and dairy products; Active components of microbial strains for the manufacture of food and pharmaceutical products; Active components resulting from the processing of microorganisms, namely, metabolites obtained from the processing of probiotic bacterial cultures for the manufacture of food and pharmaceutical products; Micro-organisms, namely, bacteria for use in food and pharmaceutical manufacturing industry; Components of micro-organisms, namely, proteins, metabolites and enzyme for industrial manufacture of food and pharmaceutical products; Micro-organism cultures, namely, lactic acid bacteria and bifidobacteria having probiotic action on the organisms of humans for use in food and pharmaceutical industry
Goods and Services
Micro-organisms culture for medical use, namely, lactic acid bacteria and bifidobacteria having probiotic activity on humans for the treatment of diseases, namely, intestinal disorders, diarrhea and to re-equilibrate the intestinal bacterial flora, for the treatment of intestinal inflammations, inflammatory bowel diseases and inflammations of the lower gastrointestinal tract, for the treatment of ulcerative colitis and Crohn's disease in which inflammation is present both in the small intestine and in the colon; Pharmaceutical products containing micro-organisms cultures, namely, lactic acid bacteria and bifidobacteria having probiotic activity on humans for the treatment of diseases, namely, intestinal disorders, diarrhea and to re-equilibrate the intestinal bacterial flora, for the treatment of intestinal inflammations, inflammatory bowel diseases and inflammations of the lower gastrointestinal tract, for the treatment of ulcerative colitis and Crohn's disease in which inflammation is present both in the small intestine and in the colon; Pharmaceutical products containing microorganisms and cultures of microorganisms, namely, probiotic lactic acid bacteria, probiotic bifidobacteria which are able to ferment and use the fibres in the human organism for the treatment of diseases, namely, intestinal disorders, diarrhea and to re-equilibrate the intestinal bacterial flora, for the treatment of intestinal inflammations, inflammatory bowel diseases and inflammations of the lower gastrointestinal tract, for the treatment of ulcerative colitis and Crohn's disease in which inflammation is present both in the small intestine and in the colon, and dietary and nutritional supplements containing microorganisms and cultures of microorganisms, namely, probiotic lactic acid bacteria, probiotic bifidobacteria which are able to ferment and use the fibres in the human organism; Pharmaceutical products for oral consumption, namely, capsules, tablets, solutions, suspensions, granules, and pellets in dried form, containing micro-organisms cultures, namely, lactic acid bacteria and bifidobacteria having probiotic activity on humans for the treatment of diseases, including, namely, intestinal disorders, diarrhea and to re-equilibrate the intestinal bacterial flora, for the treatment of intestinal inflammations, inflammatory bowel diseases and inflammations of the lower gastrointestinal tract, for the treatment of ulcerative colitis and Crohn's disease in which inflammation is present both in the small intestine and in the colon, and dietary and nutritional supplements for oral consumption, namely, capsules, tablets, solutions, suspensions, granules, and pellets in dried form, containing micro-organisms cultures, namely, lactic acid bacteria and bifidobacteria having probiotic activity on humans; Microbial and biological preparations for improving the physical well-being of humans, namely, reducing inflammation and pain; Supplements, namely, dietary supplements, for medical use and baby food, all the above containing preparations and products resulting from the processing of microorganisms, particularly metabolites obtained from the processing of probiotic bacterial cultures; Supplements, namely, dietary supplements for medical use and baby food, all the above containing liquid, solid, dried or freeze-dried microorganisms or concentrated cultures of probiotic microorganisms; ferments for medical purposes, all the foregoing being for medical and veterinary use only
Pseudo Mark
MICRO BACK
Classification Information
International Class
005 - Pharmaceutical, veterinary and sanitary preparations; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides. - Pharmaceutical, veterinary and sanitary preparations; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes
006, 018, 044, 046, 051, 052
Class Status Code
6 - Active
Class Status Date
2015-07-24
Primary Code
005
Current Trademark Owners
Party Type
30 - Original Registrant
Address
Please log in with your Justia account to see this address.
Trademark Owner History
Party Type
30 - Original Registrant
Address
Please log in with your Justia account to see this address.
Party Type
20 - Owner at Publication
Address
Please log in with your Justia account to see this address.
Party Type
10 - Original Applicant
Address
Please log in with your Justia account to see this address.
Correspondences
Name
JOHN P. MURTAUGH
Address
Please log in with your Justia account to see this address.
Foreign Application Information
Filing DateApplication NumberCountryForeign Priority Claim In
2015-04-20013964705EMFalse
2015-04-20013964705ItalyTrue
Trademark Events
Event DateEvent Description
2015-07-23NEW APPLICATION ENTERED IN TRAM
2015-07-24NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM
2015-07-25NOTICE OF PSEUDO MARK E-MAILED
2015-10-29ASSIGNED TO EXAMINER
2015-10-30NON-FINAL ACTION WRITTEN
2015-10-30NON-FINAL ACTION E-MAILED
2015-10-30NOTIFICATION OF NON-FINAL ACTION E-MAILED
2016-01-13TEAS RESPONSE TO OFFICE ACTION RECEIVED
2016-01-26ASSIGNED TO LIE
2016-01-28CORRESPONDENCE RECEIVED IN LAW OFFICE
2016-01-28TEAS/EMAIL CORRESPONDENCE ENTERED
2016-03-02EXAMINERS AMENDMENT -WRITTEN
2016-03-02EXAMINERS AMENDMENT E-MAILED
2016-03-02NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
2016-03-02EXAMINER'S AMENDMENT ENTERED
2016-03-02APPROVED FOR PUB - PRINCIPAL REGISTER
2016-03-02ASSIGNED TO LIE
2016-03-09LAW OFFICE PUBLICATION REVIEW COMPLETED
2016-03-23NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
2016-04-12PUBLISHED FOR OPPOSITION
2016-04-12OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
2016-06-28REGISTERED-PRINCIPAL REGISTER
2016-08-01PAPER RECEIVED
2016-10-31CASE ASSIGNED TO POST REGISTRATION PARALEGAL
2016-08-01SEC 7 REQUEST FILED
2016-10-31CORRECTION UNDER SECTION 7 ¿ PROCESSED
2021-06-28COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED